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Abstract
Background: With the zebrafish increasingly being used in immunology and infectious disease research, there is a
need for efficient molecular tools to evaluate immune gene expression in this model species. RT-MLPA (reverse
transcription - multiplex ligation-dependent probe amplification) provides a sensitive and reproducible method, in
which fluorescently labelled amplification products of unique lengths are produced for a defined set of target
transcripts. The method employs oligonucleotide probes that anneal to adjacent sites on a target sequence and
are then joined by a heat-stable ligase. Subsequently, multiplex PCR with universal primers gives rise to amplicons
that can be analyzed with standard sequencing equipment and relative quantification software. Allowing the
simultaneous quantification of around 40 selected markers in a one-tube assay, RT-MLPA is highly useful for high-
throughput screening applications.
Findings: We employed a dual-colour RT-MLPA probe design for chemical synthesis of probe pairs for 34 genes
involved in Toll-like receptor signalling, transcriptional activation of the immune response, cytokine and
chemokine production, and antimicrobial defence. In addition, six probe pairs were included for reference genes
unaffected by infections in zebrafish. First, we established assay conditions for adult zebrafish infected with
different strains of Mycobacterium marinum causing acute and chronic disease. Addition of competitor
oligonucleotides was required to achieve peak heights in a similar range for genes with different expression
levels. For subsequent analysis of embryonic samples it was necessary to adjust the amounts of competitor
oligonucleotides, as the expression levels of several genes differed to a large extent between adult and
embryonic tissues. Assay conditions established for one-day-old Salmonella typhimurium-infected embryos could
be transferred without further adjustment to five-day-old M. marinum-infected larvae. RT-MLPA results were
compared with results of previous transcriptome analyses and with real-time PCR data, demonstrating a good
correlation between all expression analysis methods.
Conclusions: The RT-MLPA assay developed in this study provides a rapid, cheap, and robust analysis tool for
simultaneous quantification of a set of 34 innate immune response genes. With adjustment of conditions, the assay
is suitable for infection studies in both adult and embryonic zebrafish. Application of RT-MLPA will facilitate high-
throughput screening of immune responses in the zebrafish model.
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The use of zebrafish models in immunological and
infectious disease research has rapidly expanded over
the recent years [1,2]. Important advantages of zebrafish
include its amenability to large-scale forward and
reverse genetic screening and small molecule library
screening [3,4]. The recent development of a robotic
system for bacterial infection of zebrafish embryos will
facilitate antimicrobial drug screening in this model at
high-throughput level [5]. The availability of robust
molecular tools for the rapid evaluation of immune
responses is a highly desired addition to zebrafish-based
screening approaches.
Multiplex Ligation-dependent Probe Amplification
(MLPA) is a high resolution method to establish the
copy number of around 40 nucleic acid sequences in a
one-tube reaction [6,7]. The technique was initially
developed to determine copy number variation in geno-
mic DNA, but has also been adapted for quantification
of mRNA transcript levels [8]. Since its introduction in
2002, MLPA has rapidly become accepted in genetic
diagnostic laboratories, where it is used for the detection
of disease-associated polymorphisms, deletions, duplica-
tions and rearrangements in genomic DNA [7]. Reasons
for the rapid adoption of MLPA in diagnostics are the
relative simplicity, low costs (ca. 10 euro per reaction),
high-throughput capacity, sensitivity, accuracy and
robustness of the technique. The use of reverse-tran-
scriptase-MLPA (RT-MLPA) for mRNA expression pro-
filing is less common but has proven useful for example
in human immunology and cancer research [9,10]. In
contrast to approximately 250 MLPA kits available for
DNA analysis, only three RT-MLPA kits (including a
human inflammation probe set, a human apoptosis
p r o b es e t ,a n dam o u s ei n f l a m m a t i o np r o b es e t )a r e
commercially available (MRC Holland, http://www.mlpa.
com). While the application of existing RT-MLPA tests
is fast and simple, the development of new tests for
detection of other sets of mRNAs is a significant
investment.
Setting up of an RT-MLPA test for a new set of
mRNAs requires first the design of oligonucleotide
probes. Detection of each different target sequence
requires two oligonucleotide probes, designed such that
they anneal to immediately adjacent sites on a target
cDNA sequence produced by reverse transcription of
mRNA (Figure 1A). One of the two oligonucleotide
probes contains a stuffer sequence of variable length.
Following hybridization to the target sequence, the
probe pair is ligated by a heat-stable ligase and amplified
using fluorescently labelled universal primers. The fact
that only one primer pair is used, is the prerequisite for
simultaneous reproducible amplification of different
s e q u e n c e sa n dm a k e sr e l a t i v e quantification possible
[6,8]. Oligonucleotide probes that are not ligated will
not be amplified. Due to use of different stuffer
sequences, amplification of each ligated oligonucleotide
probe pair gives rise to an amplification product of
unique length. The amplicons are separated using the
standard electrophoresis equipment that is also used for
sequence analysis and peaks are quantified using relative
quantification software.
Probes used in MLPA usually range between 80 to
400 nucleotides in length. Accurate chemical synthesis
of MLPA probes is possible up to a length of approxi-
mately 180 nucleotides, while M13 cloning (using
SALSA vectors, MRC Holland, http://www.mlpa.com) is
used to produce probes up to 400 nucleotides in length
[6,7,11]. To bypass the laborious M13 cloning proce-
dures, a dual-colour approach has been applied [12]. In
this approach, two universal primer pairs are used that
give similar amplification efficiencies but are labelled
Figure 1 Two-colour RT-MLPA assay.( A )S c h e m a t i c
representation of the RT-MLPA assay design (figure adapted from
MRC-Holland, http://www.mlpa.com). (B) Composition of the
zebrafish immune response RT-MLPA assay. Expression of genes
indicated in blue and red is detected by FAM-labelling and TR-
labelling, respectively. In addition, three reference genes (bactin1,
ppial, rplp0) are included both in the probe set for FAM-labelling
and in the probe set for TR-labelling.
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mum possible number of synthetic probe pairs in a sin-
gle MLPA assay.
Following probe design, a second time-consuming step
in development of an RT-MLPA assay is optimization of
the assay conditions by addition of competitor oligonu-
cleotides (probes without universal primer sequences).
Competitor oligonucleotides need to be used to titrate
down the signals of genes with higher expression levels
than others, such that all amplicons will produce peak
heights in a similar range [8]. Titration conditions may
need to be adjusted separately for different sample
types, for example for different tissues or for samples
from experimental manipulations that lead to large dif-
ferences in gene expression. Therefore, RT-MLPA is
most useful for high-throughput applications that
involve repetitive analysis of a targeted transcript set in
similar biological samples.
Here we describe the development of a first RT-
MLPA assay for application in zebrafish models. The
probe set targets 34 genes with functions in the innate
immune system and contains 6 probe pairs for reference
genes that are not affected under infection conditions.
We show that a dual-colour approach previously devel-
oped for MLPA [12] can also be adopted for RT-MLPA,
allowing us to combine 41 synthetic probe pairs in a
single assay. We tested the method using samples from
Mycobacterium marinum and Salmonella typhimurium
infection experiments and established assay conditions
for analysis of both adult and embryonic tissues. RT-
MLPA results correlated well with results from previous
transcriptomics studies and with results from real-time
PCR analysis.
Methods
MLPA probe and RT-primer design
MLPA probes and RT-primers were designed for target
mRNAs of 34 immune response genes and three refer-
ence genes (Additional file 1). For each target a pair of
probes was designed, binding adjacently to each other
on the target sequence, with the resulting ligation site
located maximally 7 nucleotides from an exon-exon
boundary. In addition, a control probe pair, designed on
an intron sequence of one of the targets (cxcr3.2), was
included in the set to check for the interference of
genomic DNA in the MLPA run. The probe oligos were
designed following the guidelines described in the man-
ual “Designing synthetic MLPA probes” (http://www.
mlpa.com, MRC Holland, Amsterdam, The Nether-
lands). All probe pairs contain the same universal bind-
ing site for the reverse PCR primer on the right probe
oligo (RPO). The left probe oligo (LPO) for approxi-
mately half of the immune response genes harbours a
sequence corresponding with forward PCR primer 1
labelled with FAM, while the remaining LPOs harbour a
different sequence corresponding with forward PCR pri-
mer 2 labelled with Texas Red (TR). Two different
probe pairs were designed for each of the three refer-
ence genes, one for amplification with FAM-labelled pri-
mer 1 and one for amplification with TR-labelled primer
2, thus resulting in a total of six RT-MLPA reference
sequences. The probe pairs were designed such that the
fragments resulting from PCR amplification are spaced
by a minimum of three nucleotides in a range from 91-
178 base pairs. Additionally, competitor oligonucleotides
were created, consisting of the left probe oligo hybridi-
zation sequence (LHS), but lacking the universal primer
sequence. A synthetic control DNA template was gener-
ated for each target and used to test the probe pairs for
efficiency in setting up the RT-MLPA assay and as a
positive control during runs. RT-Primers, reverse com-
plement to the strand corresponding to the probe
sequence, were designed for all target mRNAs, and were
positioned immediately adjacent to the actual MLPA
probe with no more than 15 nucleotides between the
last nucleotide of the primer and the first nucleotide of
the probe sequence, and with a maximum overlap of 7
nucleotides. The RT primers all have a Tm in the range
of 55-65 °C and a GC content between 35 and 60%.
RT-MLPA assay
RT-MLPA reactions were performed using SALSA
®
MLPA
® Reagents kit EK1-RT (MRC-Holland, Amster-
dam, The Netherlands) according to the manufacturer’s
instructions for RT-MLPA reactions (version 10, 18-09-
2008). All reaction steps were performed in a thermocy-
cler with heated lid (105°C) using 0.2 ml thin-walled
PCR tubes. RPOs were treated with T4 polynucleotide
kinase (New England Biolabs) before use to establish 5’
phosphorylation. A mix of RT-primers and dNTPs was
prepared containing 1 pmol/μlo ft h eR Tp r i m e rf o r
each target transcript and 2.5 mM of dNTPs. The RT
primer/dNTP mix (1 μl) was added to the RNA sample
(100 ng total RNA in 2.5 μl) and SALSA RT buffer (1
μl) at 4°C. This mixture was subsequently heated for 1
min to 80°C and incubated for 5 min at 45°C. Subse-
quently, the temperature was cooled down to 37°C, 30
units of M-MLV Reverse Transcriptase in SALSA dilu-
tion buffer (1.5 μl) were added, and the RT reaction was
performed for 15 min at 37°C. The RT enzyme was
then inactivated by heating to 98°C for 2 min and the
mixture was cooled down to 25°C. A probe mix contain-
ing all probe oligos was prepared containing 2 fmol/μl
of each oligo and, if necessary, competitor oligos were
added to the required ratio (Additional file 2). The
probe mix (1.5 μl) and MLPA buffer (1.5 μl) were added
to the RT reaction, and after heating for 1 min at 95°C,
the mixture was incubated for 16 h at 60°C to let the
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gets. Subsequently, the mixture was cooled down to 54°
C, 32 μl of Ligase-65 mix was added, and ligation of the
LPO and RPO probes was performed by incubating for
15 min at 54°C. The ligase enzyme was inactivated by
heating to 98°C for 2 min and the mixture was cooled
down to 4°C. Next, 10 μl of the ligation reaction was
mixed with 4 μl of SALSA PCR buffer and 26 μl water.
When the tubes were in the thermal cycler at 60°C, 10
μl of polymerase mix was added containing 2 μlo fP C R
primer mix (10 pmol/μl of each forward primer and 20
pmol/μl of the reverse primer), 2 μlS A L S AE n z y m e
Dilution Buffer, 5.5 μl water, and 0.5 μl SALSA Poly-
merase. The PCR reaction was carried out with slight
modifications to the manufacturer’s protocol to provide
higher selectivity of the PCR primers. To this end the
amplification temperature was increased to 65°C, and
the number of cycles was increased to 38, resulting in
the following cycling conditions: 30 s at 95°C; 30 s at
65°C; 1 min at 72°C. PCR cycling was ended with 20
min incubation at 72°C, after which the reaction was
cooled down to 4°C. After PCR, the resulting DNA frag-
ments were treated for 10 min at 37°C with 5 μl of Poly-
merase I Large Klenow fragment (Promega Corp.,
Madison, WI, USA) diluted in a 2.5 mM dNTP mix to
correct for strand overhang. Next, the fragments were
column-purified with the ZR DNA Sequencing Clean-up
Kit™ (Zymo Research Corporation, Orange, CA, USA),
according to the manufacturer’s instructions, to prevent
for dye-blobs in capillary fragment analysis. After PCR
purification, 0.7 μl of sample was mixed with 0.3 μlo f
GS500-LIZ size standard and fragment analysis was per-
formed on a ABI 3100 sequencer in GeneScan mode.
Data were analyzed using GeneMarker
® software, ver-
sion 1.7 (SoftGenetics, LLC. State College, PA, USA).
R a wd a t aw e r ei m p o r t e dw i t ht h eA n a l y s i sT y p es e to n
‘Fragment (Animal) Analysis’ and the following default
settings for the Data Process Options: Raw Data Analy-
sis: auto range, smooth, peak saturation, baseline sub-
traction, pull-up correction, spike removal; Size call:
Local Southern; Allele Call: auto range 60-600 with peak
detection threshold settings at: intensity > 100, percen-
tage >5, local region > 25%, max call intensity 30000;
Stutter peak filter %: left 90, right 40; Plus-A filter. Data
were scaled using the GS500-LIZ size standard and
peaks of target transcripts were assigned using a tem-
plate with the fragment sizes of the RT-MLPA amplifi-
cation products. A table containing the heights of each
assigned peak scored in arbitrary units was exported
and further analysed in Microsoft Excel. For normaliza-
tion of the data, the peak heights of the target tran-
scripts were divided by the average peak heights of the
reference genes included in the same dye group. Based
on parallel runs of the synthetic DNA control template
described above there was no need to correct for possi-
ble signal sloping. Fold change values were calculated by
dividing the normalized peak values of a treatment sam-
ple by the normalized peak values of the control sample.
Real-time PCR
From 1 μg of total RNA cDNA was synthesized using
the I-Script cDNA synthesis Kit (Bio-Rad Laboratories,
Hercules, CA, USA). For real-time PCR assays SYBR
Green Universal PCR Mastermix 2x (Applied Biosys-
tems, Foster City, CA, USA) was used. PCR primers
were designed with Primer Express Software version 1.7
(Applied Biosystems, Foster City, CA, USA). For 33 of
the 40 RT-MLPA target transcripts, including all six
reference sequences, real-time PCR primer sets were
developed, covering the hybridization sequence of each
RT-MLPA target (Additional file 1). Each real-time PCR
reaction contained 12,5 μl 2X PCR Mastermix, forward
and reverse primer in a final concentration of 300nM, 1
μl of cDNA template and the volume adjusted to 25 μl
with ddH2O. The reactions were run on an ABI
PRISM™ 7500 Sequence Detection System (Applied
Biosystems). The solution was subjected to a protocol of
subsequently 95 °C for 10 minutes, followed by 40 cycles
of 15 s at 95 °C and 1 min. at 60 °C. All reactions were
performed in duplicate. Relative quantification was per-
formed according to Vandesompele et al. [13] using
three reference genes (coding for tyrosine 3-monooxy-
genase activation protein (NM_201484), NADH dehy-
drogenase (AC024175), and 16S ribosomal RNA
(CK739347) that were selected from the GeNorm Zebra-
fish reference kit (PrimerDesign Ltd, Southampton, UK)
for normalization.
RNA samples
Total RNA samples from zebrafish adults infected with
M. marinum E11 and Mma20 strains and PBS-injected
control fish were identical to those used in a previous
microarray study [14]. Three biological replicates of
infected fish and controls were used for RT-MLPA analy-
sis, similar as in the previous microarray study. Zebrafish
embryos at 28 hours post fertilization (hpf) were injected
into the caudal vein with approximately 200 colony form-
ing units (CFU) of S. typhimurium infection or injected
with PBS as a control. Total RNA was isolated from
pools of 15-20 embryos per treatment group at 8 hours
post infection (hpi) and subjected to microarray analysis
as previously described [15]. Samples were analyzed from
three independent S. typhimurium infection experiments.
Zebrafish embryos at 48 hpf were injected into the yolk
sac with approximately 2000 CFU of M. marinum E11
bacteria in PVP carrier solution or with carrier solution
alone as a control [5]. Total RNA was isolated from pools
of 15-20 embryos at 3 days post infection (dpi).
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Development of an RT-MLPA probe set for the zebrafish
innate immune response
For rapid screening of innate immune responses in zeb-
rafish we set out to develop an RT-MLPA assay. We
adopted a two-colour assay design, which was previously
used in MLPA applications for DNA diagnostics [12].
This two-colour design, using FAM (blue) and TR (red)
dyes for multiplex PCR amplification of MLPA probes,
allowed combining 41 chemically synthesized MLPA
probes (size range: 91 to 178 oligonucleotides) in a sin-
gle reaction (Figure 1A, Additional file 1). Three refer-
ence genes, bactin1, ppial,a n drplp0, were selected
based on previous transcriptomics data showing
unchanged expression levels of these genes during M.
marinum infection of adult zebrafish and S. typhimur-
ium infection of embryos [14-19]. Two different probe
pairs were designed for each of the three reference
genes, one for amplification with FAM-label and one for
amplification with TR-label. As an internal control for
possible genomic DNA contamination, a probe pair
designed on an intron sequence of one of the target
genes was included in the probe set for amplification
with FAM-label. A total of 34 genes involved in innate
immunity were selected for probe design (Table 1). The
selection included: 9 genes involved in TLR signalling; 7
immune-related transcription factor genes; 4 genes for
pro-inflammatory cytokines and class II a-helical cyto-
kines; 8 genes for chemokines that we have found to be
induced by infections in previous transcriptomics studies
[14-19]; 2 genes for chemokine receptors; and 4 miscel-
laneous genes involved in inflammation and microbial
defense, including matrix metalloproteinase 9 (mmp9),
myeloperoxidase (mpx), a homolog of human acidic
chitinase (chia.6), and the gene for FK506 binding pro-
tein 5 (fkbp5), which is a marker for activation of gluco-
corticoid receptor signalling. These selected genes were
divided over the probe sets for amplification with FAM-
label and TR-label (Figure 1B, Additional file 1).
RT-MLPA analysis of Mycobacterium-infected zebrafish
adults
First we tested the RT-MLPA assay on samples from a
previous M. marinum infection study of adult zebrafish
[14]. In this study, two different strains of M. mari-
num, E11 and Mma20, were used that cause chronic
and acute infection, respectively, and lead to different
gene expression profiles. At 6 dpi, the acute infection
caused by Mma20 infection was accompanied by
induced microarray expression levels of the majority of
genes included in the RT-MLPA assay. Therefore,
RNA samples from this infection condition were cho-
sen to set up the RT-MLPA assay conditions. Relative
quantification in RT-MLPA analysis requires the use of
competitor oligonucleotides to titrate down the signals
of genes with higher expression levels than others. Follow-
ing titration, RT-MLPA analysis of the Mma20 infection
sample at 6 dpi showed detectable peak heights for all the
reference genes and immune response genes in the range
between 100 and 11000 relative fluorescence units (RFU)
(Figure 2). The intron control showed no detectable peak,
indicating that there was no interference from genomic
DNA contamination. The same assay conditions were then
applied to test three biological replicates of E11 and
Mma20 infections at 6 dpi, and the expression levels were
analyzed relative to samples from PBS-injected control fish.
The results showed higher induction levels in Mma20
infection than in E11 infection (Figure 2A), in agreement
with the severity of the infections caused by the two differ-
ent strains.
RT-MLPA analysis of Salmonella- and Mycobacterium-
infected zebrafish embryos
Next we performed RT-MLPA analyses on samples from
infection studies in embryos. Initial tests showed that
the assay conditions developed for samples from M.
marinum-infected adult fish were not applicable to sam-
ples from embryos, because several genes showed
strongly different basal or induced expression levels
between adult and embryonic tissues. Therefore, titra-
tion levels of competitor oligonucleotides had to be
adjusted for analysis of embryo samples. The titration
was performed on samples from S. typhimurium-
infected embryos at 8 hpi, a stage at which many of the
genes included in the RT-MLPA probe set were known
to be differentially expressed [15,16,19]. After establish-
ment of appropriate assay conditions, S. typhimurium-
induction of a broad set of immune response genes was
detected, as well as repression of the cxcr3.2 and mpx
genes (Figure 2B). A clear induction of several immune
response genes was also observed in subsequent RT-
MLPA analysis of a sample from five-day-old larvae that
had been infected three days earlier by injection of M.
marinum E11 bacteria into the yolk sac (Additional file
4). Therefore, the titration conditions set-up for one-
day-old S. typhimurium-infected embryos were also sui-
table for analysis of M. marinum infection at a later
developmental stage. However, it should be noted that
the analysis of other developmental stages or other
infection regimes, would still require a further assess-
ment of the normalising function of the reference genes
under those conditions.
Comparison of RT-MLPA and transcriptomics data
The same RNA samples as those used for RT-MLPA
analysis (Figure 2) were also subjected to microarray
analysis and the data were used for comparison with the
RT-MLPA results (Additional file 3).
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Page 5 of 10Infection of adult fish with the M. marinum E11 strain
was previously shown to lead to chronic infection with
no visible disease symptoms at 6 dpi [14]. Of all 34
immune genes included the RT-MLPA set, only one
(cxcr4b) showed a significant induction (2.1-fold) in the
previous microarray analysis [14]. The induction of this
gene was also above the 2-fold change threshold in the
RT-MLPA analysis (2.2-fold), which additionally
detected minor inductions (2.0-2.5-fold) of 6 other
genes.
Table 1 Target genes of the zebrafish immune response RT-MLPA assay
Gene
name
1
Description ZFIN ID GenBank
Accession
Entrez Gene
ID
UniGene
ID
2
Immune response genes
ccl20a chemokine ccl-c24a (si:dkey-150o13.1, ccl20) ZDB-GENE-091204-95 NM_001113595 563152 Dr.133624
ccl-c24i transcribed locus, weakly similar to NP_001108573.1 chemokine
CCL-Cub
- CN021049 - Dr.125570
ccl-c5a chemokine ccl-c5a (si:ch211-89f7.4) ZDB-GENE-060526-181 NM_001082906 794891 Dr.133987
chia.6 chitinase, acidic.6 ZDB-GENE-030131-1140 NM_199603 322420 Dr.77223
cxc46 cxc chemokine 46 ZDB-GENE-090303-1 XM_002664187 100321314 Dr.117585
cxcl-c13d chemokine cxcl-c13d - NM_001113651 100003911 Dr.92011
cxcl-c1c chemokine cxcl-c1c (si:ch73-6k14.1) ZDB-GENE-090313-165 NM_001115060 795785 Dr.113696
cxcl-c5c chemokine cxcl-c5c - NM_001115055 567537 Dr.111760
cxcr3.2 chemokine (C-X-C motif), receptor 3.2 ZDB-GENE-041114-186 NM_001007314 791973 Dr.82754
cxcr4b chemokine (C-X-C motif), receptor 4b ZDB-GENE-010614-1 NM_131834 114447 Dr.75485
fkbp5 FK506 binding protein 5 ZDB-GENE-030616-630 NM_213149 368924 Dr.78793
fos v-fos FBJ murine osteosarcoma viral oncogene homolog ZDB-GENE-031222-4 NM_205569 394198 Dr.12986
ifnphi1 interferon phi 1 ZDB-GENE-030721-3 NM_207640 360134 Dr.85981
il10 interleukin 10 ZDB-GENE-051111-1 NM_001020785 553957 Dr.135567
il1b interleukin 1, beta ZDB-GENE-040702-2 NM_212844 405770 Dr.30443
il8 interleukin 8 ZDB-GENE-081104-317 CT826376 100002946 Dr.112992
jun v-jun sarcoma virus 17 oncogene homolog (c-Jun) ZDB-GENE-030131-7859 NM_199987 335916 Dr.1064
junb jun B proto-oncogene ZDB-GENE-040426-2172 NM_213556 407086 Dr.10326
mmp9 matrix metalloproteinase 9 ZDB-GENE-040426-2132 NM_213123 406397 Dr.76275
mpx myeloid-specific peroxidase ZDB-GENE-030131-9460 NM_212779 337514 Dr.75725
myd88 myeloid differentiation primary response gene (88) ZDB-GENE-040219-3 NM_212814 403145 Dr.134592
nfkb2 nuclear factor of kappa light polypeptide gene enhancer in B-
cells 2, p49/p100
ZDB-GENE-030131-6701 NM_001001840 415100 Dr.117553
rel v-rel reticuloendotheliosis viral oncogene homolog ZDB-GENE-040718-255 NM_001001841 415101 Dr.86023
rela v-rel reticuloendotheliosis viral oncogene homolog A ZDB-GENE-040825-4 NM_001001839 415099 Dr.84126
sarm1 sterile alpha and TIR motif containing 1 ZDB-GENE-040219-1 NM_001130596 403143 Dr.84799
spi1 spleen focus forming virus (SFFV) proviral integration oncogene
spi1 (pu.1)
ZDB-GENE-980526-164 NM_198062 30117 Dr.34508
ticam1 toll-like receptor adaptor molecule 1 (ticam1, trif) ZDB-GENE-040219-2 NM_001044759 403147 Dr.82215
tirap toll-interleukin 1 receptor (TIR) domain containing adaptor
protein (tirap, mal)
ZDB-GENE-040219-4 AL916644 403148 Dr.87438
tlr1 toll-like receptor 1 ZDB-GENE-040220-1 NM_001130593 403127 Dr.89709
tlr4bb toll-like receptor 4b, duplicate b ZDB-GENE-040219-9 NM_212813 403132 Dr.89442
tlr5a toll-like receptor 5a ZDB-GENE-040219-14 AY389449 403138 Dr.89423
tlr5b toll-like receptor 5b ZDB-GENE-040219-15 NM_001130595 403139 Dr.89707
tnfa tumor necrosis factor a (TNF superfamily, member 2) ZDB-GENE-050317-1 NM_212859 405785 Dr.89727
traf6 TNF receptor-associated factor 6 ZDB-GENE-030131-5735 NM_001044752 554561 Dr.74618
Reference genes
bactin1 beta-actin 1 ZDB-GENE-000329-1 NM_131031 57934 Dr.35143
ppial peptidylprolyl isomerase A, like (cyclophilin) ZDB-GENE-030131-7459 NM_199957 335519 Dr.78109
rplp0 acidic ribosomal protein (ARP) ZDB-GENE-000629-1 NM_131580 58101 Dr.55617
1 Chemokine genes ccl-c5a, ccl-c24i, cxcl-c5c, cxcl-c1c, and cxcl-c13d are named by the chromosome on which they are located according to Nomiyama et al. [21].
All other gene names are according to ZFIN (http://www.zfin.org).
2 UniGene IDs are according to Build #122.
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previously shown to cause acute disease symptoms at 6
dpi accompanied with high induction levels of many
immune response genes [14]. In total 22 genes from the
RT-MLPA gene set showed a significant change of 2-
fold or higher in the microarray analysis. Similarly, 23
genes were above the 2-fold change threshold in the
RT-MLPA analysis, of which 18 overlapped with those
detected by microarray. All inductions above 3-fold in
the microarray analysis (17 genes) were also detected by
RT-MPLA, and, vice versa, the majority of inductions
above 3-fold in RT-MLPA were also significant in the
microarray analysis (15 out of 18 genes). Only the
inductions of sarm1 (3.1-fold) and myd88 (4.2-fold) in
RT-MLPA were not significant in the microarray results,
and the high induction of il8 in RT-MLPA (12.6-fold)
could not be verified due to its absence on the microar-
ray platform. Eight genes were induced above 5-fold in
both microarray or RT-MLPA, with mmp9 showing the
highest induction in both techniques (58-fold in micro-
array; 72-fold in RT-MLPA). Other genes showing
above 5-fold induction with only one of the two meth-
ods (7 genes excluding il8, which is absent on the
microarray) also showed clear induction in the other
method (2.8-3.9-fold). The largest quantitative difference
between the results of the two methods was observed
for il1b, which was induced 26.6-fold in the microarray
analysis and 2.8-fold in RT-MLPA.
Microarray and RT-MLPA data of S. typhimurium-
infected embryos were also in good agreement, not only
showing similar gene induction profiles but also consis-
tent down-regulation (approx. 2-fold) of cxcr3.2 and
mpx expression (Figure 2B, Additional file 3). In total 16
genes in the microarray analysis and 18 in RT-MLPA
showed fold-change differences above 2-fold, of which
13 were overlapping between the two methods. With
the exception of ccl20 (4-fold induction in microarray),
all other genes (9) showing above 3-fold change in the
microarray analysis were also picked up by RT-MLPA.
Vice versa, with the exception of tlr5b (5-fold induction
in RT-MLPA), all other genes (8) with above 3-fold
change in RT-MLPA were also significant in the micro-
array analysis. Although the induction of tlr5b was
below the 2-fold change threshold, it showed 1.7-fold
induction in the microarray analysis supported by 9
probes with a significant P-value (<0.0001).
In conclusion, both for M. marinum infection of adult
fish and for S. typhimurium infection of embryos the
results of microarray and RT-MLPA were largely consis-
tent in that differential expression of the majority of
genes tested was confirmed by both methods. As both
methods are to be considered semi-quantitative and rely
on entirely different technology and data processing, it
is not surprising that differences in the absolute
induction levels were observed. A possible explanation
for some discrepancies is that the microarray and RT-
MLPA are measuring different transcripts due to alter-
native splicing.
Validation of RT-MLPA data by real-time PCR
To further confirm the RT-MLPA results we chose to
perform real-time PCR quantification on RNA from
one of the M. marinum Mma20-infected adult fish at
6 dpi. For real-time analysis we wanted to design PCR
primers that overlapped with the hybridization
sequence regions of the RT-MLPA probes. Good pri-
mer design in these regions was possible for 27 of the
immune response genes and for the reference genes of
the RT-MLPA assay. Three additional reference genes
coding for tyrosine 3-monooxygenase activation pro-
t e i n ,N A D Hd e h y d r o g e n a s e ,a n d1 6 Sr i b o s o m a lR N A
(GeNorm zebrafish reference kit) were selected for
normalization of the real-time PCR data. These refer-
ence genes and those from the RT-MLPA assay (bac-
tin1, ppial,a n drplp0) did not show significantly
different expression between RNA samples from con-
trol and infected fish. Genes ccl20, cxcl-c5c, ifnphi1,
and jun also did not shown significant induction in
either real-time PCR or RT-MLPA. All other immune
r e s p o n s eg e n e st e s t e ds h o w e d2 - f o l do rh i g h e ri n d u c e d
expression levels in real-time PCR analysis of Mma20-
infected fish compared to uninfected controls, except
ticam1 which was just below the threshold (1.9-fold)
(Figure 3). The majority of these genes also showed 2-
fold or higher induction in RT-MLPA analysis. The
most notable exception was myd88,w h i c hw a sn o t
detectably induced in RT-MLPA compared to a 2.4-
fold change in real-time PCR (Figure 3). In addition,
three genes (cxc46, fkbp5, fos) with inductions between
2.6- and 3-fold in real-time PCR were just below the
threshold in RT-MLPA (1.7-1.9-fold). While in general
the absolute values of induction measured with real-
time PCR were higher than those measured by the
semi-quantitative RT-MLPA approach, the genes
showing the highest induction levels in real-time PCR
(ccl-c24i, il1b, mpx,a n dtnfa) also showed the highest
inductions in RT-MLPA. In conclusion, real-time PCR
confirmed the usefulness of the RT-MLPA assay for
screening innate immune gene expression.
Conclusions
In this work, we have developed an RT-MLPA analysis
panel for relative quantification of innate immune gene
expression in zebrafish. The method allows the rapid
semi-quantitative expression screening of 34 genes
involved in TLR signalling, transcriptional activation of
the immune response, cytokine and chemokine produc-
tion, and antimicrobial defence. Expression levels of
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Page 7 of 10Figure 2 RT-MLPA assays of M. marinum-infected zebrafish adults and S. typhimurium-infected zebrafish embryos. (A). Zebrafish were
infected with M. marinum strains E11 and Mma20, or injected with PBS as a control, and samples were taken at 6 dpi [14]. (B) One-day-old
zebrafish embryos (27 hpf) were intravenously infected with S. typhimurium strain SL1027, or injected with PBS as a control, and samples were
taken at 8 hpi (35 hpf). Three biological replicates were analyzed in both experiments. A representative example of the RT-MLPA assay result of
each is shown. Peak patterns of the FAM-labelled amplification products are in blue and peak patterns of the TR-labelled amplification products
are in red. Fold change values of amplification products that were more than 2-fold up-regulated in infected zebrafish compared to the
uninfected control are indicated with green arrows, and fold change values of amplification products that were more than 2-fold down-
regulated are indicated with purple arrows. Fold change values are based on the combined data from three biological replicates.
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Page 8 of 10these genes are determined relative to the expression of
three reference genes in a single tube assay. The validity
of the assay was demonstrated by comparison with tran-
scriptomic data sets and real-time PCR analysis. Differ-
ential expression levels of the immune response genes
detected with RT-MLPA covered a range between 2-fold
and over 70-fold, similar to the results of microarray
and real-time PCR analysis.
In development of the RT-MLPA assay we chose to
employ a dual-colour labelling system previously used in
DNA diagnostic MLPA applications [12]. In this system,
two probe sets, each in the size range of approximately
90 to 180 oligonucleotides, are amplified using FAM-
labelling and TR-labelling, respectively. In this size
r a n g ei ti sp o s s i b l et oc o m p o s et h eR T - M L P Aa s s a y
exclusively from synthetic probes, thus avoiding the
laborious M13 cloning procedures used previously to
extend the size range of probes for (RT-)MLPA analysis
[6-8]. For future development it may be possible to
further increase the number of testable mRNA targets
by 50% with the use of a third label, which has also
been reported in DNA diagnostic MLPA [20]. This
would also facilitate further increasing the number of
different reference genes in the assay.
The RT-MLPA assay was successfully applied to the
analysis of RNA samples from infection experiments in
adult and embryonic zebrafish. However, analysis of
adult and embryonic material required different assay
conditions. In RT-MLPA analysis it is necessary to com-
pensate for large differences in expression levels of
genes by the addition of competitor oligonucleotides to
the probe mix [8]. We found that the basal and infec-
tion-induced expression levels of several genes differed
to such an extent between adult and embryonic tissues
that titration of the probe mix with competitor oligonu-
cleotides had to be adjusted for these different develop-
mental stages. Fortunately, assay conditions established
for one-day-old S.typhimurium-infected embryos could
be transferred without further adjustment to five-day-
old M. marinum-infected larvae. Thus, by employing
two types of titration conditions, we have been able to
establish an RT-MLPA assay for infection studies in
adult zebrafish and a second RT-MLPA assay that is
applicable to infection studies in both embryos and lar-
vae and with different pathogens.
Due to the fact that RT-MLPA is a relative quantifica-
tion method, the composition of the probe mix cannot
be easily altered without adjustment of the assay condi-
tions. The replacement of one probe by another, or the
addition of a probe for a new target transcript, will
affect the peak heights of other transcripts. Therefore,
especially if the new probe results in a large peak, this
may require re-titrating the probe mix, as was also
necessary when the sample-type was changed from adult
to embryonic zebrafish. Since re-titration of the assay is
a time-consuming step, RT-MLPA analysis is most sui-
table for recurrent analysis of the same set of target
mRNAs under comparable experimental conditions. For
such medium or high throughput screening applications,
the innate immune response RT-MLPA assay developed
in this study provides a rapid, cheap, and robust analysis
tool.
Figure 3 Comparison of RT-MLPA and real-time PCR data. An RNA sample from an adult zebrafish infected with M. marinum strain Mma20
at 6 dpi was compared to a sample from a PBS-injected control fish from the same experiment [14]. Real-time PCR assays were performed in
duplicate and RT-MLPA runs were repeated four times. Data are plotted on a logarithmic scale. The red line is set at a 2-fold induction level.
Error bars indicate the standard deviation.
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Additional file 1: Supplementary Table 1. Oligonucleotide sequences
used in RT-MLPA and real-time PCR.
Additional file 2: Supplementary Table 2. Amounts of competitor
oligonucleotides in the probe mixes for RT-MLPA analysis of zebrafish
adults and embryos.
Additional file 3: Supplementary Table 3. Comparison of RT-MLPA and
microarray data.
Additional file 4: Supplementary Figure 1. RT-MLPA assay of M.
marinum-infected zebrafish embryos. Two-day-old zebrafish embryos (48
hpf) were injected in the yolk with M. marinum strain E11, or with PVP
carrier solution as a control, and samples were taken at 3 dpi (5 dpf).
RNA was isolated from pools of 15-20 embryos per treatment group. The
RT-MLPA analysis was performed in triplicate and representative
examples of the assay results are shown. Peak patterns of the FAM-
labelled amplification products are in blue and peak patterns of the TR-
labelled amplification products are in red. Fold change values of
amplification products that were more than 2-fold up-regulated in
infected zebrafish compared to the uninfected control are indicated with
green arrows.
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